Join
Live feed
·
INSIDERFilingvia Quantisnow
Black Diamond Therapeutics Inc. logo

Director Campbell Shannon was granted 2,011 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BDTX· Black Diamond Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BDTX (Black Diamond Therapeutics Inc.) and more on Quantisnow.

Director Campbell Shannon was granted 2,011 shares (SEC Form 4) | Quantisnow